Published in Chem Soc Rev on June 28, 2012
In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma. EMBO Mol Med (2015) 1.83
Disclosing the CXCR4 expression in lymphoproliferative diseases by targeted molecular imaging. Theranostics (2015) 1.11
The ubiquitin-CXCR4 axis plays an important role in acute lung infection-enhanced lung tumor metastasis. Clin Cancer Res (2013) 1.08
Bimodal imaging probes for combined PET and OI: recent developments and future directions for hybrid agent development. Biomed Res Int (2014) 0.88
Bridged cyclams as imaging agents for chemokine receptor 4 (CXCR4). Nucl Med Biol (2014) 0.86
Structural characterization and in vivo evaluation of β-Hairpin peptidomimetics as specific CXCR4 imaging agents. Mol Pharm (2015) 0.81
Use of a single hybrid imaging agent for integration of target validation with in vivo and ex vivo imaging of mouse tumor lesions resembling human DCIS. PLoS One (2013) 0.80
Biomarkers in preclinical cancer imaging. Eur J Nucl Med Mol Imaging (2015) 0.78
Molecular imaging: the emerging role of optical imaging in nuclear medicine. Eur J Nucl Med Mol Imaging (2014) 0.77
Selecting Targets for Tumor Imaging: An Overview of Cancer-Associated Membrane Proteins. Biomark Cancer (2016) 0.77
The influence of different metal-chelate conjugates of pentixafor on the CXCR4 affinity. EJNMMI Res (2016) 0.77
Design, synthesis and in vitro characterization of fluorescent and paramagnetic CXCR4-targeted imaging agents. Am J Nucl Med Mol Imaging (2013) 0.76
Hybrid Imaging Labels: Providing the Link Between Mass Spectrometry-Based Molecular Pathology and Theranostics. Theranostics (2017) 0.75
A fully human CXCR4 antibody demonstrates diagnostic utility and therapeutic efficacy in solid tumor xenografts. Oncotarget (2016) 0.75
Al[(18)F]NOTA-T140 Peptide for Noninvasive Visualization of CXCR4 Expression. Mol Imaging Biol (2016) 0.75
Obtaining control of cell surface functionalizations via Pre-targeting and Supramolecular host guest interactions. Sci Rep (2017) 0.75
The dual role and therapeutic potential of high-mobility group box 1 in cancer. Oncotarget (2017) 0.75
Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma. Blood (2007) 3.67
Bmi1 controls tumor development in an Ink4a/Arf-independent manner in a mouse model for glioma. Cancer Cell (2007) 3.14
Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer. Proc Natl Acad Sci U S A (2007) 2.39
Disease-associated prion protein oligomers inhibit the 26S proteasome. Mol Cell (2007) 2.01
P-glycoprotein and breast cancer resistance protein: two dominant transporters working together in limiting the brain penetration of topotecan. Clin Cancer Res (2007) 1.74
Validity of bioluminescence measurements for noninvasive in vivo imaging of tumor load in small animals. Biotechniques (2007) 1.66
A fluorescent broad-spectrum proteasome inhibitor for labeling proteasomes in vitro and in vivo. Chem Biol (2006) 1.54
Comparing the hybrid fluorescent-radioactive tracer indocyanine green-99mTc-nanocolloid with 99mTc-nanocolloid for sentinel node identification: a validation study using lymphoscintigraphy and SPECT/CT. J Nucl Med (2012) 1.53
Effect of the ATP-binding cassette drug transporters ABCB1, ABCG2, and ABCC2 on erlotinib hydrochloride (Tarceva) disposition in in vitro and in vivo pharmacokinetic studies employing Bcrp1-/-/Mdr1a/1b-/- (triple-knockout) and wild-type mice. Mol Cancer Ther (2008) 1.36
Feasibility of sentinel node biopsy in head and neck melanoma using a hybrid radioactive and fluorescent tracer. Ann Surg Oncol (2011) 1.25
Low systemic exposure of oral docetaxel in mice resulting from extensive first-pass metabolism is boosted by ritonavir. Cancer Res (2002) 1.21
Multimodal tumor-targeting peptides functionalized with both a radio- and a fluorescent label. Bioconjug Chem (2010) 1.20
A self-assembled multimodal complex for combined pre- and intraoperative imaging of the sentinel lymph node. Nanotechnology (2010) 1.18
Tracer-cocktail injections for combined pre- and intraoperative multimodal imaging of lymph nodes in a spontaneous mouse prostate tumor model. J Biomed Opt (2011) 1.16
Concomitant radio- and fluorescence-guided sentinel lymph node biopsy in squamous cell carcinoma of the oral cavity using ICG-(99m)Tc-nanocolloid. Eur J Nucl Med Mol Imaging (2012) 1.15
Image-guided hepatopancreatobiliary surgery using near-infrared fluorescent light. J Hepatobiliary Pancreat Sci (2012) 1.14
The effect of P-gp (Mdr1a/1b), BCRP (Bcrp1) and P-gp/BCRP inhibitors on the in vivo absorption, distribution, metabolism and excretion of imatinib. Invest New Drugs (2008) 1.10
Restricted brain penetration of the tyrosine kinase inhibitor erlotinib due to the drug transporters P-gp and BCRP. Invest New Drugs (2010) 1.09
Re: Steven Joniau, Laura Van den Bergh, Evelyne Lerut, et al. Mapping of pelvic lymph node metastases in prostate cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.06.057. Eur Urol (2012) 1.09
Optical imaging as an expansion of nuclear medicine: Cerenkov-based luminescence vs fluorescence-based luminescence. Eur J Nucl Med Mol Imaging (2013) 1.09
In vitro toxicity studies of polymer-coated gold nanorods. Nanotechnology (2010) 1.03
Profiling proteasome activity in tissue with fluorescent probes. Mol Pharm (2007) 1.01
Synthesis and evaluation of a bimodal CXCR4 antagonistic peptide. Bioconjug Chem (2011) 0.99
Light interactions with gold nanorods and cells: implications for photothermal nanotherapeutics. Nano Lett (2011) 0.95
Rapid and robust transgenic high-grade glioma mouse models for therapy intervention studies. Clin Cancer Res (2010) 0.93
Selective self-organization of guest molecules in self-assembled molecular boxes. J Am Chem Soc (2005) 0.92
Image navigation as a means to expand the boundaries of fluorescence-guided surgery. Phys Med Biol (2012) 0.91
Relationship between intraprostatic tracer deposits and sentinel lymph node mapping in prostate cancer patients. J Nucl Med (2012) 0.90
Fluorescence guidance in urologic surgery. Curr Opin Urol (2012) 0.90
Hybrid peptide dendrimers for imaging of chemokine receptor 4 (CXCR4) expression. Mol Pharm (2011) 0.90
Sentinel lymph node biopsy for prostate cancer: a hybrid approach. J Nucl Med (2013) 0.89
Radium-223 chloride: Extending life in prostate cancer patients by treating bone metastases. Clin Cancer Res (2013) 0.89
(Non-targeted) radioactive/fluorescent nanoparticles and their potential in combined pre- and intraoperative imaging during sentinel lymph node resection. Nanotechnology (2010) 0.89
Peptide-functionalized luminescent iridium complexes for lifetime imaging of CXCR4 expression. Chembiochem (2011) 0.88
Targeted non-covalent self-assembled nanoparticles based on human serum albumin. Biomaterials (2011) 0.88
Dual-emissive quantum dots for multispectral intraoperative fluorescence imaging. Biomaterials (2010) 0.86
Multispectral visualization of surgical safety-margins using fluorescent marker seeds. Am J Nucl Med Mol Imaging (2012) 0.85
Questioning the value of (99m)Tc-HYNIC-annexin V based response monitoring after docetaxel treatment in a mouse model for hereditary breast cancer. Appl Radiat Isot (2010) 0.84
Immunohistochemical detection of the CXCR4 expression in tumor tissue using the fluorescent peptide antagonist Ac-TZ14011-FITC. Transl Oncol (2011) 0.84
Determination of topotecan in human and mouse plasma and in mouse tissue homogenates by reversed-phase high-performance liquid chromatography. Biomed Chromatogr (2007) 0.83
Phosphorescence imaging of living cells with amino acid-functionalized tris(2-phenylpyridine)iridium(III) complexes. Inorg Chem (2012) 0.83
Multimodal interventional molecular imaging of tumor margins and distant metastases by targeting αvβ3 integrin. Chembiochem (2012) 0.83
Sentinel Lymph Node Biopsy in Vulvar Cancer Using Combined Radioactive and Fluorescence Guidance. Int J Gynecol Cancer (2015) 0.82
Development of a Hybrid Tracer for SPECT and Optical Imaging of Bacterial Infections. Bioconjug Chem (2015) 0.82
Differential effects of anticoagulants on tumor development of mouse cancer cell lines B16, K1735 and CT26 in lung. Clin Exp Metastasis (2008) 0.82
Tumor bracketing and safety margin estimation using multimodal marker seeds: a proof of concept. J Biomed Opt (2010) 0.81
Potential value of color-coded dynamic breast-specific gamma-imaging; comparing (99m)Tc-(V)-DMSA, (99m)Tc-MIBI, and (99m)Tc-HDP in a mouse mammary tumor model. Appl Radiat Isot (2010) 0.80
Use of a single hybrid imaging agent for integration of target validation with in vivo and ex vivo imaging of mouse tumor lesions resembling human DCIS. PLoS One (2013) 0.80
Self-assembled ionophores from isoguanosine: diffusion NMR spectroscopy clarifies cation's and anion's influence on supramolecular structure. Chemistry (2007) 0.80
Trabectedin (ET-743, Yondelis) is a substrate for P-glycoprotein, but only high expression of P-glycoprotein confers the multidrug resistance phenotype. Invest New Drugs (2007) 0.79
A pilot study of SPECT/CT-based mixed-reality navigation towards the sentinel node in patients with melanoma or Merkel cell carcinoma of a lower extremity. Nucl Med Commun (2016) 0.79
First Robotic SPECT for Minimally Invasive Sentinel Lymph Node Mapping. IEEE Trans Med Imaging (2015) 0.79
Validation of intratracheal instillation of lung tumour cells in mice using single photon emission computed tomography/computed tomography imaging. Lab Anim (2009) 0.78
Biomarkers in preclinical cancer imaging. Eur J Nucl Med Mol Imaging (2015) 0.78
Noninvasive functional imaging of P-glycoprotein-mediated doxorubicin resistance in a mouse model of hereditary breast cancer to predict response, and assign P-gp inhibitor sensitivity. Eur J Nucl Med Mol Imaging (2008) 0.77
An activatable, polarity dependent, dual-luminescent imaging agent with a long luminescence lifetime. Chem Commun (Camb) (2014) 0.77
Dendritic ruthenium(II)-based dyes tuneable for diagnostic or therapeutic applications. Chemistry (2010) 0.77
First-in-human evaluation of a hybrid modality that allows combined radio- and (near-infrared) fluorescence tracing during surgery. Eur J Nucl Med Mol Imaging (2015) 0.76
Fluorescent radiocolloids: are hybrid tracers the future for lymphatic mapping? Eur J Nucl Med Mol Imaging (2015) 0.76
Regulatory strategies in the complexation and release of a noncovalent guest trimer by a self-assembled molecular cage. Angew Chem Int Ed Engl (2003) 0.75
Photocontrolled release and uptake of a porphyrin guest by dithienylethene-tethered beta-cyclodextrin host dimers. Chemistry (2004) 0.75
Erratum to: First-in-human evaluation of a hybrid modality that allows combined radio- and (near-infrared) fluorescence tracing during surgery. Eur J Nucl Med Mol Imaging (2015) 0.75
The effect of P-glycoprotein and cytochrome P450 3a on the oral bioavailability of vinorelbine in mice. Cancer Chemother Pharmacol (2005) 0.75
Size-Sorting and Pattern Formation of Nanoparticle-Loaded Micellar Superstructures in Biconcave Thin Films. ACS Nano (2017) 0.75
Enhanced luminescence of Ag nanoclusters via surface modification. Nanotechnology (2013) 0.75
Cannulation of the jugular vein in mice. Lab Anim (2005) 0.75